Becker's Healthcare March 22, 2024
Paige Twenter

On March 22, the FDA granted emergency use authorization to Pemgarda, a COVID-19 preventive medication, for patients 12 and older.

Pemgarda (pemivibart) is a monoclonal antibody that targets the SARS-CoV-2 spike protein. Clinicians are authorized to administer the drug, which must be infused for at least an hour and be followed by a repeat dose every three months.

...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, FDA, Govt Agencies, Healthcare System, Patient / Consumer, Pharma / Biotech, Provider, Public Health / COVID
President-elect Trump's picks for CDC, FDA, surgeon general: 31 notes
Opinion: RFK Jr. and MAHA should champion a Marshall Plan for obesity
Trump picks Johns Hopkins surgeon to head FDA: 10 things to know
Regulatory Hurdles and Ethical Concerns Beset FDA Oversight of AI/ML Devices
Will Trump's healthcare appointments bring 'radical changes'?

Share This Article